FTC Sues 'Middlemen' For Inflating Insulin Drug Prices
The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
FTC sues prescription drug middlemen, alleging they conspired over high insulin costs
The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns the companies are artificially inflating the list price of insulin drugs.
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.
FTC sues drug middlemen over manipulating the insulin market
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in exchange for keeping lower-cost insulin off their lists of approved
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.
FTC sues drug middlemen over manipulating insulin prices
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in exchange for keeping lower-cost insulin off their lists.
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin prices and steering patients toward higher-cost insulin products to increase their profits.
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
thelundreport2d
Health care giant sues to stop antitrust probe of pharmacy drug middlemen
The owner of one of the three largest pharmacy middlemen in the United States on Tuesday filed suit to quash an attempt by ...
Cleveland.com on MSN3d
Ohio Supreme Court nixes suit against ‘submetering’ company between renters and utilities
COLUMBUS, Ohio – The state Supreme Court on Wednesday dismissed a lawsuit challenging a regulatory ruling that leaves ...
Express Scripts sues FTC over report blasting pharmacy middlemen
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and ...
Crain's New York3d
Lawsuits against changes to home care program mount as state forges ahead
With a new lawsuit filed in federal court Wednesday, pressure is mounting to derail a plan to wipe out the sector of ...